Merit Financial Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Merit Financial Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.3M	Buy	5,380 +1,303	+32%	+$285K	0.01%	950
2026 Q1	$771K	Buy	4,077 +643	+19%	+$112K	0.01%	1118
2025 Q4	$584K	Buy	3,434 +50	+1%	+$7.67K	﹤0.01%	1214
2025 Q3	$446K	Buy	3,384 +412	+14%	+$49.4K	﹤0.01%	1246
2025 Q2	$315K	Buy	2,972 +707	+31%	+$76.8K	﹤0.01%	1315
2025 Q1	$281K	Buy	+2,265	New	+$295K	﹤0.01%	1145

Other funds holding JAZZ

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

ACM

Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

BCM

BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Merit Financial Group's JAZZ Position: Q2 2026 in Review

Merit Financial Group increased its Jazz Pharmaceuticals (JAZZ) stake by 32% in Q2 2026, buying an estimated $285K and bringing the position to 5,380 shares worth $1.3M. The position accounts for 0.01% of the portfolio, ranked #950.

Merit Financial Group first reported a position in JAZZ in Q1 2025 and has held it in 6 quarters since. 89 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Merit Financial Group held 5,380 shares of Jazz Pharmaceuticals worth $1.3M as of Q2 2026.
Merit Financial Group bought 1,303 Jazz Pharmaceuticals shares in Q2 2026, an estimated $285K.
Jazz Pharmaceuticals made up 0.01% of Merit Financial Group's portfolio in Q2 2026, its #950 holding.
Merit Financial Group first reported a position in Jazz Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
89 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.